Toggle navigation
Home
Search
Services
Blog
Contact
About
Broad Spectrum RNAi Antiviral against Hemorrhagic Fever Virus
Alnylam Pharmaceuticals, Cambridge, MA, United States
Search grants from Alnylam Pharmaceuticals
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Molecular mechanisms of DNA replication
Neuronal Oscillations and Dysregulated Motor Learning in Parkinsonian Rats
Signal Processing Strategies for Cochlear Prosthesis
Mechanisms and Prevention of Hemoglobin Neurotoxicity
Kinin Receptors - Molecular Properties and Regulation
Recently added grants:
Atherogenic Mechanisms of Electronic Nicotine Delivery Systems
Work Requirements and Health Care Disparities in Medicaid: A Randomized Controlled Trial
A gender and culturally specific approach to reduce NAFLD in Mexican American men
Improving Spatiotemporal Precision in Noninvasive Electrical Neuromodulation
Improving the HIV Care Cascade in Kenya through Implementation Science Training
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI60012-2-0-1
Application #
7699990
Study Section
Project Start
2006-09-29
Project End
2010-09-28
Budget Start
Budget End
Support Year
Fiscal Year
2008
Total Cost
$7,547,998
Indirect Cost
Institution
Name
Alnylam Pharmaceuticals
Department
Type
DUNS #
115524410
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Comments
Be the first to comment on this grant
